Related Experiment Video
Updated: May 14, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
In brief: cell senescence
1Tayside Tissue Bank, Level 5, Jacqui Wood Cancer Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK. p.j.coates@dundee.ac.uk
Abstract:
Cellular senescence is a key process that limits cancer development. The basics of our current understanding of the process are presented, including the genetic and epigenetic events that lead to the senescent phenotype. In addition to limiting replicative lifespan, senescence appears to act as a potent signal to activate immune clearance and alter the microenvironment. Finally, senescence induction is an area for anti-cancer therapeutic development, but will require the development of appropriate assays to identify the relevant target(s) in individual tumours.
Insights
Cellular senescence, a process limiting cancer, involves genetic and epigenetic changes. Harnessing senescence induction for cancer therapy requires new methods to identify therapeutic targets in tumors.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Cellular senescence is a fundamental biological process that acts as a crucial barrier against cancer development.
- Understanding the genetic and epigenetic underpinnings of senescence is key to its therapeutic exploitation.
- Senescence influences the tumor microenvironment and immune surveillance, impacting cancer progression.
Purpose of the Study:
- To present the fundamental aspects of cellular senescence.
- To explore the genetic and epigenetic factors driving senescence.
- To discuss the potential of senescence induction as an anti-cancer therapeutic strategy.
Main Methods:
- Review of current literature on cellular senescence.
- Analysis of genetic and epigenetic events leading to the senescent phenotype.
- Discussion of immune clearance and microenvironment alteration mechanisms.
Main Results:
- Cellular senescence limits cancer development by restricting cell proliferation.
- Senescence induction involves specific genetic and epigenetic alterations.
- Senescence signals immune cells and modifies the tumor microenvironment.
Conclusions:
- Cellular senescence is a vital anti-cancer mechanism.
- Targeting senescence for cancer therapy holds promise.
- Development of assays to identify senescence targets in individual tumors is crucial for therapeutic success.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cells Coordinate Growth and Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Apoptosis

